September 27, 2019 -- Intact Vascular, Inc. announced 1-year results of its TOBA III clinical trial, which achieved both primary and secondary endpoints. Marianne Brodmann, MD…
September 2019—Atherosclerotic disease in the bifurcating femoral artery remains hostile anatomy for endovascular intervention. The angled ostia of the superficial femoral artery (SFA) and p…
September 2019—PATIENT HISTORY
A 62-year-old man presented with a 2-month history of worsening bilateral calf pain (worse in the left leg) when walking one block. He complained of numbnes…
September 25, 2019 -- MedAlliance announced that the FDA awarded Breakthrough Device designation status for the company's Selution SLR, a sustained limus-release drug-elut…
September 24, 2019 -- iVascular, based in Barcelona, Spain, announced that 6-month results of the TINTIN study were presented by Principal Investigator Koen Deloose, MD, at CI…
September 19, 2019 -- LimFlow SA, a France-based developer of minimally invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), announced that the F…
September 17, 2019 -- Orchestra BioMed, Inc., in partnership with Terumo Corporation, announced that the FDA has granted Breakthrough Device designation for its Virtue sirolim…
September 12, 2019 -- Rex Medical, LP announced that it has received FDA 510(k) clearance for the Revolution peripheral atherectomy system. The Revolution device is indic…